Master Psychiatrist
Call Toll Free
877-225-8384

It Doesn’t Need to Be This Way
– Join The World’s Most Powerfully Practical Master Psychopharmacology Course

Dear Colleague,

Despite my rich experience as a psychiatrist treating thousands of patients, I still frequently confront clinical conundrums when treating challenging patients. To be frank, at those times I wish I had a “master consultant” – or, better yet, a group of master consultants, each an expert in their particular area of psychiatry – to whom I could turn to for advice.

Unfortunately, these wise men and women are not sitting around waiting for my phone call. So, are there more realistic resources I can turn to? There are, of course, thousands of books available on various aspects of psychiatric management. But, as of yet, we don’t have interactive books to whom I could present my clinical question and receive an individualized answer. And most current books simply do not delve into the intricacies of day-to-day clinical care.

Also, dozens of psychiatric conferences are held each year. So how good of a resource are they? I’d like to ask you to think for a moment about the conferences you have attended. Which scenario below more closely mirrors what you normally experience at these events? Your answer will shed light on our main question: why is prescribing so often like a shot in the dark?


Which of These Sounds Like a Conference You’ve Attended?

Conference “X” Conference “M”

When lecturing about a new medication, the speakers present outcomes of large studies. They wow you with graphs, tables, and levels of statistical significance. Their conclusions, however, remain generic, with bullet points stating that this or that new medication is a worthwhile addition to our armamentarium and that more studies are indicated.

At the end of the lecture, you file out of the conference room with a generally warm feeling of having learned something. You can’t really repeat, however, what you learned if someone asked you to summarize the main learning points of the lecture. And when you return to your office, nothing much changes in how you consider your medication options or what you prescribe to your patients.

The speakers distill the state of the knowledge and then present concrete advice on how to incorporate the new medication under discussion into existing treatment algorithms and how to effectively and safely prescribe this medication. They present details of the pre-administration workup and ongoing monitoring guidelines. They then present real life clinical vignettes illustrating their decision-making and the benefits and challenges of maintaining a patient on this medication. They conclude by providing an extensive (a really extensive) question-and-answer period so audience members have a chance for a “consultation” focused on their particular clinical conundrum.

You leave the lecture speaking excitedly with other participants about the nuances of the medication. You discuss amongst yourselves how you plan to use the medication and which patients are most likely to benefit. You exchange emails. When you return home you have a clear sense of when and how to use this new medication. When a patient asks you for details of the side effects and why you think this is the best med for them, your answer is clear and convincing. You are left with a feeling of clarity and confidence in your practical knowledge – in your ability to prescribe the medication safely and effectively without a need to second-guess your decision.


The Master Psychopharmacology Course Is Born!

The scenarios I presented above are not hypothetical. The Conference ‘X’ describes my typical conference experience in my 20 years as a psychiatrist attending annual meetings and other psychiatric conferences. It is the type of experience that led me one day to stop and think – to virtually shout out loud – “There has to be a better way! I need something more from these meetings!”

And it was from this sense of frustration that conference “M” or the Master Psychopharmacology Course was born. It is my solution to meeting the needs of the psychiatrist who sits across from one or two dozen patients each day and makes crucial decisions about each of these from the patient's treatment.

Now, after having held five Master Psychopharmacology Courses, I can say with assurance that we have developed a course that is packed with practical, clinically-relevant, master-level, and down-in-the-trenches detailed prescribing guidance.

When you look at the faculty for this Master Psychopharmacology Home Study Course, you will recognize most of our faculty members and may even have heard many of them speak. But – and this is important – the approach they take at the Master Psychopharmacology Course differs from their standard style. We have worked with this esteemed faculty – cajoled, begged, and even bullied them – to present the most practical and clinically relevant information so that your prescribing decisions are made with confidence and clarity.

If I sound like a zealot on the point of practicality, I guess I have to plead guilty. I not only promise you “actionable knowledge,” I guarantee it, as you’ll read below.

Earn Up To 24.5 Hours of AMA / PRA CME Credit

Your CMEs are included in the tuition of the Master Psychopharmacology Home Study Course. Nothing additional to buy! Note that many employers, group practices and training programs will reimburse you for the costs of a Cat 1 CME activity. If you’re not sure if yours does, it’s worth finding out

One more thing. The Master Psychopharmacology Course includes an additional intensive segment, that we call, Legal Armor for the Psychiatrist.

Additional Legal Armor for the Psychiatrist 50% Off
Reason #7

The Master Psychopharmacology Course comes with an additional segment called Legal Armor for the Psychiatrist.

Over the years we’ve received countless questions about malpractice risk which is a frequent source of concern and unease among physicians. So we have produced an integrated course led by two very experienced forensic psychiatrists, Drs. James L. Knoll IV and Phillip J. Resnick.

Legal Armor for the Psychiatrist gives you a way to protect yourself and to live with a much higher level of security and comfort. The faculty members tell you how you can protect yourself, to add certain steps to your procedures, and to stop doing some things you may be doing that may be placing you at increased risk, whether or not you realize that they are risky and avoidable. And if you are involved in a medical malpractice case (an estimated 75% of psychiatrists will), the faculty will address step-by-step how best to proceed and what critical actions you must take. Since the focus is on practical information you can apply to your day-to-day practice, you receive actionable guidance and plenty of time to ask questions of the faculty regarding any type of medical-legal concern you may have.

In my opinion, Legal Armor for the Psychiatrist is crucial to your career success and to your peace of mind. Just think how one small tip – out of many you’ll learn – could possibly save you from a painful confrontation with the legal system. This course is truly a gift of learning you can give yourself that will continue to provide you with protection for the rest of your career.

And if you order the Master Psychopharmacology Home Study Course, you are eligible for a 50% Legal Armor for the Psychiatrist tuition discount.

Legal Armor for the Psychiatrist

 
1.5 Hours Malpractice Law for Psychiatrists
  • Overview Of Tort Law
  • Element Of Negligence
  • Standards Of Care
  • Malpractice Defenses
 
1.5 Hours Trends in Psychiatric Malpractice
  • Common Causes Of Action
  • Informed Consent
  • Duty To Third Parties
  • Sexual Misconduct
 
1 Hour Prevention of Psychiatric Malpractice
  • Staying Current With Suicide Research
  • Approach To Suicide Risk Assessment
  • Documenting A Suicide Risk Assessment & Risk Management Plan
 
1 Hour 200 Malpractice Cases - Lessons Learned
  • Real World Observations From Malpractice Litigation
  • The Defendant Psychiatrist's Deposition
 
1 Hour Risk Assessment for Suicide Including Documentation
  • Risk Factors For Suicide
  • Protective Factors
  • Analysis Of Suicide Attempts
  • Documentation Of Suicide Risk
 
1 Hour Risk Assessment for Violence Including Documentation
  • Risk Factors For Violence
  • Structured Instrument
  • Paranoia And Violence
  • Documentation Of Violence Risk
  • Violence Prevention Plans
 
Return to Top

Adult Master Psychopharmacology Course

 
1.5 Hours Treatment of Alcohol and Drug Abuse
  • When to use pharmacotherapy
  • How to use acamprosate, naltrexone, and disulfiram for patients with alcohol dependence
  • Opioid dependence pharmacotherapy: buprenorphine, methadone, and oral and injectable naltrexone
  • Integrating pharmacotherapy with psychosocial treatments and self-help groups such as AA
  • Increasing medication adherence in substance dependent patients
 
2 Hours Managing the Dually Diagnosed Patient
  • Clinical approaches to the “dual diagnosis” patient
  • Solving diagnostic difficulties: Substance-induced psychiatric symptoms vs. a separate psychiatric disorder?
  • Pharmacotherapy of psychiatric disorders in patients with co-occurring substance use disorders
  • Is it safe and effective to use anti-craving agents in patients with co-occurring psychiatric illness?
  • Integrated treatment of substance dependent individuals with coexisting conditions
2 Hours Modern Management Of Cognition And Mood In Older Adults
  • Know How To Perform An Efficient Assessment To Diagnosis A Range Of Cognitive And Mood Disorders In Older Adults
  • Become Knowledgeable Of Pharmacological Treatments For These Conditions
  • Develop An Awareness Of The Importance Of Non-Pharmacological Strategies For Augmenting Pharmacotherapy
 
1.5 Hours Psychopharmacology Of Obsessive Compulsive Spectrum Disorders
  • Practical Review Of Neurobiology Neurocircuitry Of OCD
  • Review Of Obsessive Compulsive Disorders
 
 
1.5 Hours Managing The Adult Patient With An Autism Spectrum Disorder
  • Overview Of Target Symptom Domains In ASD And Impact On Functioning Practical Review Of Neurobiology And Neurocircuitry
  • Psychopharmacology Of Social Cognition
  • Psychopharmacology Of Repetitive Behaviors
  • Psychopharmacology Of Disruptive Behaviors
  • Psychopharmacology Of Attention, Mood Instability And Epilepsy
  • Novel Treatment Strategies
 
1.5 Hours Course and Treatment of Mood Disorders During Pregnancy
  • Review The Course Of Psychiatric Illness During Pregnancy
  • During Pregnancy
  • Available Pharmacologic Treatment Options For Treating The Spectrum Of Psychiatric Disorders Seen In Reproductive Age Women
  • Treatment Algorithms For Use Of The Range Of Psychotropics During Pregnancy
 
1.5 Hours Screening and Treatment of Postpartum Psychiatric Disorders : An Update
  • Review The Various Screening Tools Which Are Available To Identify PPD
  • Data From The Array Of Pharmacologic And Non-Pharmacologic Treatment Studies Of PPD Will Be Critically Reviewed So That Clinicians Can Choose The Ideal Treatment To Match The Variety Of Postpartum Presentations Seen In Clinical Practice
 
1.5 Hours Understanding Drug-Drug Interactions And Avoiding Untoward Outcomes
  • A primer on kinetic and pharmacodynamic interactions
  • Review of the big 4 pharmacokinetic mechanisms
  • A Primer on pharmacogenomics
  • Review of drug-drug interactions
  • Everything you wanted to know about PGP but were afraid to ask
 
 
2.5 Hours Identification and Management of Cardiometabolic Risk With Antipsychotic Medications
  • Recognize the Risk of Premature Mortality Associated with Major Mental Illness, The Major Contribution Of Cardiovascular Disease And "Risk Equivalent" Conditions Like Diabetes
  • Identify The Increased Prevalence Of Specific Medical Conditions Among The Mentally Ill Population
  • Describe Commonly Occurring Cardiometabolic Risk Factors
  • Identify The Risk Of Cardiometabolic Side Effects Of Commonly Used Psychotropic Medications
  • Recognize Pharmacological And Behavioral Strategies To Modify Treatment Risk
  • Understand Methods To Detect Cardiometabolic Risk, As Well As Barriers To Screening, Monitoring And Management
 
Return to Top

Course Faculty

Lee Cohen, MD
Lee Cohen, MD

Titles/Affiliations/Positions:

  • Associate Professor, Harvard Medical School, Boston, MA
  • Associate Psychiatrist, Massachusetts General Hospital, Boston, MA
  • Director, Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Boston, MA

Education:

  • MD, Albany Medical College, Albany, NY
  • Residency in Psychiatry, Massachusetts General Hospital, Boston, MA
  • Clinical Fellow in Psychiatry, Harvard Medical School, Boston, MA

For more than 20 years, Dr. Cohen has been actively engaged in research, teaching, and clinical care related to psychiatric disorders throughout the female reproductive lifecycle.

After completing a chief residency in psychiatry, he founded the Perinatal and Reproductive Psychiatry Clinical Research Program, where he serves as Director. Along with colleagues in the Perinatal Program, Dr. Cohen helped to create and maintain the Perinatal Information Resource Center at www.womensmentalhealth.org.

Dr. Cohen has given more than 200 lectures nationally and internationally on issues in women’s mental health, as well as chairing numerous symposia. He also has experience in directing continuing medical education courses in the area of reproductive psychiatry.

Dr. Cohen has also shared his expertise through the authorship of more than 100 peer-reviewed articles and 30 book chapters. He is an ad hoc reviewer for more than 20 scholarly medical journals, an editorial board member for Archives of Women’s Mental Health, and co-editor of the text Mood and Anxiety Disorders During Pregnancy and Postpartum.

Eric Hollander, MD, DFAPA, FACNP
Eric Hollander, MD, DFAPA, FACNP

Titles/Affiliations/Positions:

  • Clinical Professor, Psychiatry and Behavioral Science, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
  • Director, Autism and Obsessive-Compulsive Spectrum Program, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Education:

  • MD, State University of New York, Downstate Medical College, Brooklyn, NY
  • Resident and Chief Resident, Psychiatry, Mt. Sinai School of Medicine, New York, NY
  • NIMH Research Fellowship, Columbia University College of Physicians and Surgeons, Manhattan, NY

Dr. Hollander has been listed under NY Magazine’s “Best Doctors” and “Best Doctors in America” numerous times. He has also received national research awards from the American Psychiatric Association and a Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Depression. Dr. Hollander has served as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry and Director of the Seaver and Greater NY Autism Center for Excellence at Mount Sinai School of Medicine.

Dr. Hollander has published more than 450 scientific reports and edited nearly 20 books in the psychiatry field including The Clinical Manual of Impulse Control Disorders (2006). Dr. Hollander has also made frequent television appearances on Dateline NBC and the Today Show, as well as having interviews in the New York Times and People Magazine.

James L. Knoll IV, MD
James L. Knoll IV, MD

Titles/Affiliations/Positions:

  • Director, Forensic Psychiatry, SUNY Upstate Medical University, Syracuse, NY
  • Editor in Chief, Psychiatric Times
  • Associate Professor, Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Education:

  • MD, University of Texas Southwestern Medical School, Dallas, TX
  • Resident of Psychiatry, University of Texas Southwestern Medical School, Dallas, TX
  • Fellow, Forensic Psychiatry, Case Western Reserve University, Cleveland, OH

Dr. Knoll, who has been listed in “Best Doctors in America” by Central New York Magazine, has worked extensively in the field of Forensic Psychiatry. He has served as a forensic evaluator for state and federal courts, corrections, and the private sector. He is currently the Editor-In- Chief of the Psychiatric Times and Co-Editor of the Correctional Mental Health Report.

Dr. Knoll has collaborated with both the FBI and the American Society for Industrial Security to publish guidelines for reducing workplace violence. He has also authored over 100 articles and book chapters.

Jack Krasuski, MD
Jack Krasuski, MD

Position

  • Adjunct Assistant Professor of Psychiatry, University of Illinois, Chicago, IL
  • Executive Director, American Physician Institute for Advanced Professional Studies, Oak Brook, IL

Education

  • MD, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL
  • Residency, Dept. of Psychiatry, University of Illinois Medical Center and Clinics at Chicago, Chicago, IL
  • Fellowship, Senior Staff Fellow at the National Institute on Aging, National Institutes of Health, Bethesda, MA

Dr. Krasuski spent three years as a Senior Staff Fellow at the National Institute on Aging, NIH, where he did research in the neuroimaging of dementing disorders. Currently, he spends most of his time lecturing to thousands of physicians yearly on psychiatric topics. He is known for his ability to clearly explain complex and little understood topics.

John W. Newcomer, MD
John W. Newcomer, MD

Position

  • Senior Associate Dean, Clinical Research, Leonard M. Miller School of Medicine, University of Miami, Miami, FL
  • Professor, Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, FL

Education

  • MD, Wayne State University School of Medicine, Detroit, MI

Dr. Newcomer has been lecturing in the field of psychiatry for over 20 years. He has received numerous honors and awards including Distinguished Fellow of the American Psychiatric Association. Dr. Newcomer has served as Director for the Clinical Trials Unit, Institute for Clinical & Translational Science, Washington University, and as member of the Interventions Committee for Schizophrenia Spectrum Disorders, Personality Disorders, and Disorders of Late Life for the National Institute of Mental Health.

Dr. Newcomer has published hundreds of psychiatric reports, abstracts, and chapters, along with serving on numerous editorial boards including Schizophrenia Bulletin and Neuropsychopharmacology.

Phillip J. Resnick, MD
Phillip J. Resnick, MD

Position

  • Professor, Case Western Reserve University School of Medicine, Cleveland, OH
  • Adjunct Professor, Case Western Reserve University School of Law, Cleveland, OH
  • Director, Division of Forensic Psychiatry, Case Western Reserve University, Cleveland, OH

Education

  • MD, Case Western Reserve University, Cleveland, OH
  • Fellowship, William Beaumont Hospital, El Paso, TX
  • Residency, University Hospitals of Cleveland, Cleveland, OH

Dr. Phillip J. Resnick is a leading international authority on forensic psychiatry, specializing in the clinical prediction of the risk of violence and the assessment of malingering and deception. He has consulted on and / or provided expert testimony as a witness on a number of well-known criminal cases including those of Jeffrey Dahmer, Timothy McVeigh, Susan Smith, Andrea Yates and the Unabomber. Dr. Resnick is also a past president of the American Academy of Psychiatry and the Law. He has written extensively on forensic topics and is widely considered to be one of the most outstanding speakers in the field of forensic psychiatry today.

Gary W. Small, MD
Gary W. Small, MD

Position

  • Professor, Department of Psychiatry and Behavioral Sciences, UCLA, Los Angeles, CA
  • Founding Director, UCLA Memory Clinic, UCLA, Los Angeles, CA
  • Founding Director, Memory and Aging Research Center, Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
  • Director, UCLA Center on Aging, Los Angeles, CA

Education

  • MD, University of Southern California School of Medicine, Los Angeles, CA
  • Chief Resident, Psychiatric Consultation-Liaison, Massachusetts General Hospital, Boston, MA
  • Fellow in Geriatric Psychiatry, UCLA School of Medicine, Los Angeles, CA

Gary Small, M.D., is Professor of Psychiatry and Biobehavioral Sciences, the Parlow-Solomon Professor on Aging at the David Geffen School of Medicine at UCLA, Director of the UCLA Longevity Center on Aging, and Director of the Geriatric Psychiatry Division at the Semel Institute for Neuroscience & Human Behavior.

Dr. Small has authored over 500 scientific works and received numerous awards and honors, including Senior Investigator Award, American Association for Geriatric Psychiatry, and the Weinberg Award for Excellence in Geriatric Psychiatry from the American Psychiatric Association. Scientific American magazine named him one of the world’s top innovators in science and technology. He is co-author (with Gigi Vorgan) of several popular books, including the New York Times best seller, The Memory Bible, as well as The Memory Prescription, The Longevity Bible, iBrain, The Other Side of the Couch (Los Angeles Times best seller), and The Alzheimer’s Prevention Program. Dr. Small’s discoveries have made the headlines of The New York Times, Wall Street Journal, and USA Today, and he frequently appears on The Today Show, Good Morning America, PBS, and CNN.

Roger Weiss, MD
Roger Weiss, MD

Position

  • Professor of Psychiatry, Harvard Medical School, Boston, MA
  • Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA

Board Certifications

  • Psychiatry
  • Addiction Psychiatry

Education

  • MD, Tufts University School of Medicine, Medford, MA
  • Resident, Psychiatry, McLean Hospital, Belmont, MA

Dr. Weiss has been lecturing for more than 20 years throughout the country on the topics of alcohol and drug abuse. He has received numerous awards in recognition of his work, including the 14th Annual H. David Archibald Award for Outstanding Research and/or Practice in the Addictions, Centre for Addiction and Mental Health, Toronto and Distinguished Fellow, American Psychiatric Association. Dr. Weiss is the Chief of the Division of Alcohol and Drug Abuse at McLean Hospital; he serves as the Vice President of Greater Boston Council of Alcoholism and has served as a member of the Treatment Research Committee on the National Institute on Drug Abuse.

Dr. Weiss serves on the editorial board of numerous journals including the American Journal of Drug and Alcohol Abuse and is a reviewer for at least 15 scholarly medical journals. He has published more than 300 journal articles and book chapters, as well as researching in the field of alcohol and drug abuse for more than 25 years.

Return to Top

Register Today

So, to start accessing the proven, practical and up-to-date guidance in the Master Psychpharmacolgoy 3 Home Study Course, register online or call us today. Hundreds of your colleagues already have!

Sincerely,

Jack Krasuski MD

Jack Krasuski MD
Executive Director &
Medical Editor

Master Psychopharmacology PLUS Legal Armor Intensive


Home Study Materials
Available Now

$690

Register Now

Master Psychopharmacology



Home Study Materials
Available Now

$495

Register Now

Return to Top

Additional Medical Update for  the Psychiatrist Intensive 50% Off

PS: Dear Colleague,

Jack Krasuski MD

As Psychiatrists, we constantly seek out ways to improve our practices through meetings and seminars. The problem is that most psychopharmacology courses present lots of theory with no direct guidance. The speakers don’t put themselves on the line by presenting concrete guidelines for prescribing. They talk about research and trials – but how does that help you, when you’re face-to-face with a tough, treatment-resistant patient?

The Master Psychopharmacology Home Study Course is different. We give you actionable, down-in-the-trenches guidance on how to effectively expand your armamentarium and improve your day-to-day patient care. The knowledge that comes from decades of investigation is now presented to you in clear and practical terms.

If this is the type of guidance you’re looking for in pharmacotherapy (with the Master Psychopharmacology Course) and in risk reduction (with the Legal Armor for the Psychiatrist course) then I ask you to register to order the home study today.

Jack Krasuski MD

Jack Krasuski MD
Executive Director
877-225-8384

Register Today

So, to start accessing the proven, practical and up-to-date guidance in the Master Psychpharmacolgoy 3 Home Study Course, register online or call us today. Hundreds of your colleagues already have!

Sincerely,

Jack Krasuski MD

Jack Krasuski MD
Executive Director &
Medical Editor

Master Psychopharmacology PLUS Legal Armor Intensive


Home Study Materials
Available Now

$690

Register Now

Master Psychopharmacology



Home Study Materials
Available Now

$495

Register Now

Return to Top

Return to Top
Call Toll-Free to Register 877-225-8384
Interested in Other Specialties? View the Full List of American Physician Institute Course Offerings Below.

Anesthesiology

Anesthesiology Board Prep

Emergency Medicine

Emergency Medicine Board Prep

Family Medicine Board Prep

Hospice & Palliative Care Board Prep

Internal Medicine Board Prep

Critical Care Medicine

Cardiovascular Disease Board Prep

Pulmonary Disease

Pulmonary Disease Board Prep

Sleep Medicine

Sleep Medicine Board Prep

General Surgery Board Prep

Vascular Surgery Board Prep

Master Series Courses

©2011 American Physician Institute for Advanced Professional Studies, All rights reserved.
About | Contact Us | Copyright | Privacy | Unsubscribe
Authorize.net
American Physician Institute for Advanced Professional Studies, LLC, Tutoring, Oak Brook, IL